Health Care & Life Sciences » Pharmaceuticals | Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,270
1,525
1,659
1,821
2,443
4,186
Depreciation, Depletion & Amortization
234
255
276
271
294
382
Other Funds
36
155
57
9,146
34
836
Funds from Operations
1,139
1,714
1,879
1,863
2,617
3,595
Changes in Working Capital
588
577
608
1,022
359
2,835
Net Operating Cash Flow
1,727
2,291
2,487
2,886
2,259
6,430
Capital Expenditures
442
449
636
266
227
Sale of Fixed Assets & Businesses
5
19
1
28
17
Purchase/Sale of Investments
5
-
457
79
2,733
Net Investing Cash Flow
445
434
1,086
314
2,942
Cash Dividends Paid - Total
98
374
446
570
525
Issuance/Reduction of Debt, Net
206
52
75
725
16
Net Financing Cash Flow
267
476
428
7,851
575
Net Change in Cash
1,015
1,381
972
10,421
1,258
Free Cash Flow
1,285
1,842
1,851
2,619
2,032
Deferred Taxes & Investment Tax Credit
187
67
17
46
92
137
Net Assets from Acquisitions
-
-
11
6
-
Other Sources
-
-
-
-
-
Exchange Rate Effect
-
-
1
1
2
Other Uses
4
4
5
2
-

About Guangzhou Baiyunshan Pharmaceutical Holdings Co.

View Profile
Address
No. 45 Sha Mian North Street
Guangzhou Guangdong 510130
China
Employees -
Website http://www.gpc.com.cn
Updated 07/08/2019
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. engages in the manufacture, wholesale, retail, import, and export of pharmaceutical products, medical apparatus, and Chinese medicine. It operates in the following segments: Great Southern TCM, Great Commerce, and Great Health. The Great Southern TCM segment provides Chinese and Western medicine, chemicals for medicine, natural drugs, biological medicine.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.